A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
2020 · Science · 1,560 citations
https://doi.org/10.1126/science.abc6952
X
Xiangyang Chi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
2.1K
Citations
14
h-index
19
i10-index
Xiangyang Chi is an academic researcher from Academy of Military Medical Sciences. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Monoclonal and Polyclonal Antibodies Research & Viral Infections and Outbreaks Research. The author has an h-index of 14, co-authored 39 publications.
ORCID: 0000-0002-0580-5997Papers by this author
worksIntegrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization
2021 · Cell Discovery · 33 citations
https://doi.org/10.1038/s41421-021-00300-2
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
2023 · Cell Discovery · 15 citations
https://doi.org/10.1038/s41421-023-00535-1
A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramer
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-48601-w
A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2
2024 · Emerging Microbes & Infections · 4 citations
https://doi.org/10.1080/22221751.2024.2373307
Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp)
2025 · Viruses · 2 citations
https://doi.org/10.3390/v17091157
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat